Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non-small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) production
about
Statins and cancersSuppression of interactions between prostate tumor cell-surface integrin and endothelial ICAM-1 by simvastatin inhibits micrometastasisNOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling.Statin use and risk of lung cancer: a meta-analysis of observational studies and randomized controlled trials.Reciprocal activation between IL-6/STAT3 and NOX4/Akt signalings promotes proliferation and survival of non-small cell lung cancer cells.Relationship between expression of NADPH oxidase 2 and invasion and prognosis of human gastric cancerStatin use and risk for ovarian cancer: a Danish nationwide case-control study.Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study.Sanguinarine inhibits vascular endothelial growth factor release by generation of reactive oxygen species in MCF-7 human mammary adenocarcinoma cells.TIPE2 suppresses angiogenesis and non-small cell lung cancer (NSCLC) invasiveness via inhibiting Rac1 activation and VEGF expression.Exploitation of pleiotropic actions of statins by using tumour-targeted delivery systems.Mixed-ligand mononuclear copper(II) complex: crystal structure and anticancer activity.The paradoxical pro- and antiangiogenic actions of resveratrol: therapeutic applications in cancer and diabetes.HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties.Structures and anti-cancer properties of two binuclear copper complexes.Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro.
P2860
Q26777793-1ACA5CE8-9B97-4763-A590-8D1367197747Q33684159-82A72E0F-F409-4821-8D47-2ED24F8116CFQ34100976-132324E8-F5F3-4BED-8D53-FB751C0C9B5EQ35035835-81185E97-E2D9-4988-A997-65486F6D1931Q35176004-4579626C-07E3-4047-93AA-9095C6112E17Q35651532-3022BA48-C41B-4FEC-92EC-F64E7972D28AQ35677748-C7C9F499-2ED6-4827-88E6-6340DF35F60EQ36269651-40475ACE-0AE6-47D2-83AA-68B118A9101CQ36904634-D4DAC8DA-FA6A-40EA-A91D-7A62DAF3F5FAQ37641756-3FB91597-07A9-475D-AB5A-2AAFCD159216Q38572098-807E602D-B9CA-4FB9-A5C1-AD60F021058BQ38993875-00FD7B78-FFB9-441B-BA8A-85454E17E501Q39018218-86CEB8B2-67D8-4BFF-8BB9-3443F92B0F8AQ39041630-8BA85123-0BA5-4FAC-A474-D4D1EAC1B613Q44452152-FCCF6498-9992-456C-9411-959F13D308CAQ47193411-0D648FA8-1FE5-4DB0-8DDC-6EAC512354DD
P2860
Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non-small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) production
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Atorvastatin reduces vascular ...... xygen species (ROS) production
@en
Atorvastatin reduces vascular endothelial growth factor
@nl
type
label
Atorvastatin reduces vascular ...... xygen species (ROS) production
@en
Atorvastatin reduces vascular endothelial growth factor
@nl
prefLabel
Atorvastatin reduces vascular ...... xygen species (ROS) production
@en
Atorvastatin reduces vascular endothelial growth factor
@nl
P2093
P2860
P1433
P1476
Atorvastatin reduces vascular ...... xygen species (ROS) production
@en
P2093
Jiayi Yuan
Jingjie Zhang
P2860
P356
10.1016/J.MOLONC.2011.11.003
P50
P577
2011-11-22T00:00:00Z